Invivo Therapeutics Holdings Corp (NVIV) Stock Has Fallen -9.13% This Week: Buy, Hold, or Sell?

Tuesday, December 06, 2022 03:31 PM | InvestorsObserver Analysts

Mentioned in this article

Invivo Therapeutics Holdings Corp (NVIV) Stock Has Fallen -9.13% This Week: Buy, Hold, or Sell?

Invivo Therapeutics Holdings Corp (NVIV) stock has fallen -85.34% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives NVIV stock a score of 14 out of a possible 100.

That rank is influenced by a long-term technical score of 2. NVIV's rank also includes a short-term technical score of 39.

NVIV has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on NVIV!

See Full NVIV Report

What's Happening with NVIV Stock Today

Invivo Therapeutics Holdings Corp (NVIV) stock has fallen -8.25% while the S&P 500 has fallen -1.83% as of 3:20 PM on Tuesday, Dec 6. NVIV has fallen -$0.17 from the previous closing price of $2.06 on volume of 58,305 shares. Over the past year the S&P 500 is down -14.50% while NVIV has fallen -85.34%. NVIV lost -$8.01 per share in the over the last 12 months. Click Here to get the full Stock Report for Invivo Therapeutics Holdings Corp stock.